{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:14:38Z","timestamp":1790255678733,"version":"4.1.0"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["2-SRA-2014-146-Q-R"],"award-info":[{"award-number":["2-SRA-2014-146-Q-R"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["4KF01"],"award-info":[{"award-number":["4KF01"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["COHK8"],"award-info":[{"award-number":["COHK8"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS059422"],"award-info":[{"award-number":["NS059422"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY018358"],"award-info":[{"award-number":["EY018358"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY028861"],"award-info":[{"award-number":["EY028861"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HG005033"],"award-info":[{"award-number":["HG005033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0202436","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T17:42:39Z","timestamp":1536774159000},"page":"e0202436","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization"],"prefix":"10.1371","volume":"13","author":[{"given":"Danielle","family":"McAnally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khandaker","family":"Siddiquee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Vasile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela B.","family":"Divlianska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyamaheshwar","family":"Peddibhotla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo J.","family":"Morfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hershberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Falter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Farjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-9740","authenticated-orcid":true,"given":"Layton H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"D Pascolini","year":"2012","journal-title":"The British journal of ophthalmology"},{"key":"ref2","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"S Resnikoff","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2006.10.023","article-title":"Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study","volume":"114","author":"R Varma","year":"2007","journal-title":"Ophthalmology"},{"key":"ref4","unstructured":"(2013) Prevalence of Adult Vision Impairment and Age-Related Eye Diseases in America. NEI Office of Science Communications, Public Liaison, and Education."},{"key":"ref5","first-page":"182","article-title":"Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression","volume":"40","author":"H Ozaki","year":"1999","journal-title":"Investigative ophthalmology & visual science"},{"key":"ref6","first-page":"353","article-title":"Age-related macular degeneration (AMD): pathogenesis and therapy","volume":"58","author":"JZ Nowak","year":"2006","journal-title":"Pharmacological reports: PR"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","article-title":"Retinal ischemia: mechanisms of damage and potential therapeutic strategies","volume":"23","author":"NN Osborne","year":"2004","journal-title":"Progress in retinal and eye research"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/CS20120212","article-title":"Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy","volume":"124","author":"JL Wilkinson-Berka","year":"2013","journal-title":"Clinical science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration","volume":"26","author":"N Ferrara","year":"2006","journal-title":"Retina"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbrc.2011.04.014","article-title":"Comparing protein VEGF inhibitors: In vitro biological studies","volume":"408","author":"L Yu","year":"2011","journal-title":"Biochemical and biophysical research communications"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial","volume":"119","author":"U Chakravarthy","year":"2012","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","volume":"113","author":"RL Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","article-title":"Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment","volume":"26","author":"RL Avery","year":"2006","journal-title":"Retina"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"RL Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","article-title":"Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration","volume":"26","author":"RF Spaide","year":"2006","journal-title":"Retina"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"G Bergers","year":"2008","journal-title":"Nature reviews Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/pr.114.010215","article-title":"The great escape; the hallmarks of resistance to antiangiogenic therapy","volume":"67","author":"JR van Beijnum","year":"2015","journal-title":"Pharmacological reviews"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors","volume":"3","author":"M Saint-Geniez","year":"2008","journal-title":"PloS one"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1167\/iovs.13-13397","article-title":"Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy","volume":"55","author":"CC Tokunaga","year":"2014","journal-title":"Investigative ophthalmology & visual science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)61231-X","article-title":"Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function","volume":"167","author":"AG Marneros","year":"2005","journal-title":"The American journal of pathology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/eye.2014.64","article-title":"Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD","volume":"28","author":"C Ehlken","year":"2014","journal-title":"Eye"},{"key":"ref22","first-page":"1857","article-title":"Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review","volume":"10","author":"S Yang","year":"2016","journal-title":"Drug design, development and therapy"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.1021\/bi030049s","article-title":"Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor","volume":"42","author":"X Fan","year":"2003","journal-title":"APJ. Biochemistry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.M908417199","article-title":"Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin","volume":"275","author":"M Hosoya","year":"2000","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1471-4159.2003.01587.x","article-title":"Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin","volume":"84","author":"AD Medhurst","year":"2003","journal-title":"J Neurochem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"DK Lee","year":"2000","journal-title":"J Neurochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"K Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"C Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.bjp.0703939","article-title":"[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man","volume":"132","author":"SD Katugampola","year":"2001","journal-title":"Br J Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/bbrc.2001.6230","article-title":"Apelin (65\u201377) activates extracellular signal-regulated kinases via a PTX-sensitive G protein","volume":"290","author":"B Masri","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/HJH.0b013e32834347de","article-title":"Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production","volume":"29","author":"K Siddiquee","year":"2011","journal-title":"Journal of hypertension"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejheart.2008.06.002","article-title":"The role of apelin in cardiovascular function and heart failure","volume":"10","author":"B Chandrasekaran","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","article-title":"Vascular effects of apelin in vivo in man","volume":"52","author":"AG Japp","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCULATIONAHA.109.911339","article-title":"Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure","volume":"121","author":"AG Japp","year":"2010","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCRESAHA.107.158659","article-title":"Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload","volume":"101","author":"K Kuba","year":"2007","journal-title":"Circ Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/1028415031000111273","article-title":"Inhibitory effect of apelin-12 on nocturnal food intake in the rat","volume":"6","author":"M O'Shea","year":"2003","journal-title":"Nutr Neurosci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00351-3","article-title":"Intracerebroventricular injection of apelin-13 reduces food intake in the rat","volume":"353","author":"D Sunter","year":"2003","journal-title":"Neurosci Lett"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.physbeh.2006.06.006","article-title":"Effects of central and peripheral injections of apelin on fluid intake and cardiovascular parameters in rats","volume":"89","author":"A Mitra","year":"2006","journal-title":"Physiol Behav"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/JOE-09-0134","article-title":"Abnormal fluid homeostasis in apelin receptor knockout mice","volume":"202","author":"EM Roberts","year":"2009","journal-title":"J Endocrinol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1006\/bbrc.2002.6575","article-title":"The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats","volume":"291","author":"S Taheri","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.2741\/2967","article-title":"Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1","volume":"13","author":"F Li","year":"2008","journal-title":"Front Biosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/abbs\/gmq035","article-title":"PI3K\/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13","volume":"42","author":"C Liu","year":"2010","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.peptides.2006.10.005","article-title":"Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K\/Akt signaling pathways","volume":"28","author":"SY Tang","year":"2007","journal-title":"Peptides"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ydbio.2006.04.452","article-title":"Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo","volume":"296","author":"CM Cox","year":"2006","journal-title":"Dev Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbrc.2004.10.042","article-title":"Apelin is a novel angiogenic factor in retinal endothelial cells","volume":"325","author":"A Kasai","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/ATVBAHA.108.163402","article-title":"Retardation of retinal vascular development in apelin-deficient mice","volume":"28","author":"A Kasai","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ydbio.2007.03.004","article-title":"Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis","volume":"305","author":"RE Kalin","year":"2007","journal-title":"Dev Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1167\/iovs.13-11611","article-title":"Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system","volume":"54","author":"C Hara","year":"2013","journal-title":"Investigative ophthalmology & visual science"},{"key":"ref49","article-title":"Apelin Is a Crucial Factor for Hypoxia-Induced Retinal Angiogenesis","author":"A Kasai","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref50","first-page":"5313","article-title":"The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma","volume":"34","author":"J Muto","year":"2014","journal-title":"Anticancer research"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/CIRCRESAHA.108.179333","article-title":"Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis","volume":"103","author":"M Eyries","year":"2008","journal-title":"Circ Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2009-07-232306","article-title":"Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia","volume":"115","author":"H Kidoya","year":"2010","journal-title":"Blood"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.emboj.7601982","article-title":"Spatial and temporal role of the apelin\/APJ system in the caliber size regulation of blood vessels during angiogenesis","volume":"27","author":"H Kidoya","year":"2008","journal-title":"EMBO J"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.108.174847","article-title":"Apelin-APJ signaling in retinal angiogenesis","volume":"28","author":"Y Kojima","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1160\/TH08-06-0358","article-title":"Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin\/APJ and angiopoietin\/Tie2 interactions in vessel caliber size regulation","volume":"101","author":"N Takakura","year":"2009","journal-title":"Thromb Haemost"},{"key":"ref56","unstructured":"Khan P, Maloney PR, Hedrick M, Gosalia P, Milewski M, Li L, et al. (2010) Functional Agonists of the Apelin (APJ) Receptor. Probe Reports from the NIH Molecular Libraries Program. Bethesda (MD)."},{"key":"ref57","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.bmcl.2012.08.105","article-title":"Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor","volume":"22","author":"PR Maloney","year":"2012","journal-title":"Bioorganic & medicinal chemistry letters"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"15062","DOI":"10.1038\/s41598-017-15602-3","article-title":"An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice","volume":"7","author":"Y Ishimaru","year":"2017","journal-title":"Scientific reports"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-61779-909-9_8","article-title":"Characterization of G-protein coupled receptor modulators using homogeneous cAMP assays","volume":"897","author":"DL Bassoni","year":"2012","journal-title":"Methods in molecular biology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"BF O'Dowd","year":"1993","journal-title":"Gene"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/2472555217691719","article-title":"Discovery of Novel Gq-Biased LPA1 Negative Allosteric Modulators","volume":"22","author":"Y Shimizu","year":"2017","journal-title":"SLAS discovery"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.1997.tb06793.x","article-title":"Some quantitative uses of drug antagonists. 1958","volume":"120","author":"O Arunlakshana","year":"1997","journal-title":"British journal of pharmacology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/ATVBAHA.112.300317","article-title":"Apelin\/APJ signaling is a critical regulator of statin effects in vascular endothelial cells\u2014brief report","volume":"32","author":"DL McLean","year":"2012","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/ATVBAHA.110.219980","article-title":"Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension","volume":"31","author":"SM Chandra","year":"2011","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.regpep.2004.10.019","article-title":"Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells","volume":"126","author":"MJ Kleinz","year":"2005","journal-title":"Regul Pept"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"186946","DOI":"10.1155\/2015\/186946","article-title":"Apelin Protects Primary Rat Retinal Pericytes from Chemical Hypoxia-Induced Apoptosis","volume":"2015","author":"L Chen","year":"2015","journal-title":"Journal of ophthalmology"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.febslet.2004.05.038","article-title":"VIGR\u2014a novel inducible adhesion family G-protein coupled receptor in endothelial cells","volume":"569","author":"C Stehlik","year":"2004","journal-title":"FEBS letters"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/383447a0","article-title":"Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor","volume":"383","author":"OB Goodman Jr.","year":"1996","journal-title":"Nature"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"9247","DOI":"10.1074\/jbc.M108490200","article-title":"beta-Arrestin\/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin","volume":"277","author":"SA Laporte","year":"2002","journal-title":"The Journal of biological chemistry"},{"key":"ref70","article-title":"In Vitro and In Vivo Assessment of ADME and PK Properties During Lead Selection and Lead Optimization\u2014Guidelines, Benchmarks and Rules of Thumb","author":"TDY Chung","year":"2004"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery","volume":"9","author":"DA Smith","year":"2010","journal-title":"Nature reviews Drug discovery"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/jpet.300.2.399","article-title":"Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate","volume":"300","author":"XQ Li","year":"2002","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1167\/iovs.15-18239","article-title":"Species Cross-Reactivity of Antibodies Used to Treat Ophthalmic Conditions","volume":"57","author":"Y Irani","year":"2016","journal-title":"Investigative ophthalmology & visual science"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"25509","DOI":"10.1038\/srep25509","article-title":"A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy","volume":"6","author":"RS Sulaiman","year":"2016","journal-title":"Scientific reports"},{"key":"ref75","article-title":"Identification and functional analysis of endothelial tip cell-enriched genes","author":"R Del Toro","year":"2010","journal-title":"Blood"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0037-1616232","article-title":"Extracellular proteolysis and angiogenesis","volume":"86","author":"MS Pepper","year":"2001","journal-title":"Thrombosis and haemostasis"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1002\/jps.23312","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: amodiaquine hydrochloride","volume":"101","author":"A Nair","year":"2012","journal-title":"Journal of pharmaceutical sciences"},{"key":"ref78","first-page":"CD000016","article-title":"Amodiaquine for treating malaria","author":"P Olliaro","year":"2003","journal-title":"The Cochrane database of systematic reviews"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(86)92371-8","article-title":"Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria","volume":"1","author":"CS Hatton","year":"1986","journal-title":"Lancet"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/bmj.292.6522.721","article-title":"Amodiaquine induced agranulocytosis and liver damage","volume":"292","author":"KA Neftel","year":"1986","journal-title":"British medical journal"},{"key":"ref81","first-page":"2644","article-title":"Adverse reactions to chloroquine and amodiaquine as used for malaria prophylaxis: a review of the literature","volume":"33","author":"R Wittes","year":"1987","journal-title":"Canadian family physician Medecin de famille canadien"},{"key":"ref82","unstructured":"(1985) Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. MMWR Morbidity and mortality weekly report. 1985\/04\/12 ed: Centers for Disease Control and Prevention. pp. 185\u2013190, 195."},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archopht.1982.01030040278015","article-title":"Amodiaquine ocular changes","volume":"100","author":"LW Hirst","year":"1982","journal-title":"Archives of ophthalmology"},{"key":"ref84","unstructured":"Maloney PR, Khan P, Hedrick M, Gosalia P, Milewski M, Li L, et al. (2010) Functional antagonists of the Apelin (APJ) receptor. Probe Reports from the NIH Molecular Libraries Program. Bethesda (MD)."},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ajpath.2012.12.020","article-title":"Targeting the IRE1alpha\/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization","volume":"182","author":"L Liu","year":"2013","journal-title":"The American journal of pathology"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1167\/iovs.11-8728","article-title":"gamma-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines","volume":"53","author":"X Qi","year":"2012","journal-title":"Investigative ophthalmology & visual science"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"e0171940","DOI":"10.1371\/journal.pone.0171940","article-title":"Oxidative stress-mediated NFkappaB phosphorylation upregulates p62\/SQSTM1 and promotes retinal pigmented epithelial cell survival through increased autophagy","volume":"12","author":"C Song","year":"2017","journal-title":"PloS one"},{"key":"ref88","article-title":"HTS Assay Validation","author":"PW Iversen","year":"2004"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of an inhibitor which causes 50 per cent inhibition (Im) of an enzymatic reaction","volume":"22","author":"Y Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1021\/ml400176n","article-title":"Discovery of ML314, a Brain Penetrant Non-Peptidic beta-Arrestin Biased Agonist of the Neurotensin NTR1","volume":"4","author":"S Peddibhotla","year":"2013","journal-title":"Receptor. ACS medicinal chemistry letters"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0202436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T07:15:24Z","timestamp":1720595724000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0202436"}},"subtitle":[],"editor":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":90,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0202436","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]}}}